Inventor · disambiguated record
Kyle J. Eastman
Also filed as: EASTMAN KYLE · EASTMAN KYLE J
20 granted patents·13 pending applications·75 citations·filing 2010–2024
92Inventor score
Files withACHILLION PHARMACEUTICALS INC11VIIV HEALTHCARE UK NO 5 LTD8HALDA THERAPEUTICS OPCO INC7BRISTOL MYERS SQUIBB CO5BENDER JOHN A1
Top patents by PatentIndex Score
33 records- 0198US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
- 0298US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
- 0397US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
- 0497US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
- 0597US11053253B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·16 cites·9 claims
- 0696US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
- 0796US11718626B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Aug 8, 2023·3 cites·21 claims
- 0886US11814391B2Macrocyclic compounds for the treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 14, 2023·3 cites·17 claims
- 0982US9738653B2Fused furans for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·3 cites·3 claims
- 1081US12297205B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted May 13, 2025·0 cites·15 claims
- 1173US8962651B2Compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Feb 24, 2015·1 cites·8 claims
- 1272US10189816B2Substituted pyridines as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Granted Jan 29, 2019·1 cites·8 claims
- 1370US10351546B2Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Granted Jul 16, 2019·1 cites·19 claims
- 1456US2025136611A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2024·Application pending·0 cites
- 1553US12479856B2Pharmaceutical compounds for the treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
- 1652US2019092754A15-(n-benzyl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 1752US2025388575A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 1852US2024238424A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 1952US2025388605A1Heterobifunctional compounds and methods of treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2023·Application pending·0 cites
- 2050US2025032623A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2150US2025136619A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2249US2020268897A1Phosphatase Binding Compounds and Methods of Using SameUNIV YALE·Filed 2020·Application pending·0 cites
- 2347US2024408093A1Heterobifunctional compounds and their use in treating diseaseHALDA THERAPEUTICS OPCO INC·Filed 2022·Application pending·0 cites
- 2446US2023022157A1Pharmaceutical compounds for the treatment of complement factor d medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2543US10214534B2Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 26, 2019·0 cites·8 claims
- 2641US2020016136A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 2740US2020055839A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2018·Application pending·0 cites
- 2836US10065953B2Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2015·Granted Sep 4, 2018·0 cites·10 claims
- 2936US2018147196A1Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2016·Application pending·0 cites
- 3035US9957278B2Furopyridine compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 1, 2018·0 cites·3 claims
- 3135US9249152B2Cyano containing azabenzofuran compounds for the treatment of hepatitis CBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 2, 2016·0 cites·23 claims
- 3235US8143244B2Cyclopropyl fused indolobenzazepine HCV NS5B inhibitorsBENDER JOHN A·Filed 2010·Granted Mar 27, 2012·0 cites·13 claims
- 3334US9938271B2Inhibitors of human immunodeficiency virus replicationVIIV HEALTHCARE UK NO 5 LTD·Filed 2015·Granted Apr 10, 2018·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Kyle J. Eastman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →